NCT04198766 · Interventional trial
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Gastric Cancer, Head and Neck Cancer, Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Resectable Non-Small-Cell Lung Cancer, Solid Tumor, Urothelial Carcinoma
Delaware Valley sites
- MD Anderson Cancer Center at Cooper · Camden, NJ · Camden County · Not yet recruiting
First posted
Registry updated
Added to the directory